BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 24625943)

  • 21. Xanthoma disseminatum associated with inflammatory arthritis and synovitis--a rare association.
    Gupta P; Khandpur S; Vedi K; Singh MK; Walia R
    Pediatr Dermatol; 2015; 32(1):e1-4. PubMed ID: 25496014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Xanthoma disseminatum with progressive involvement of the central nervous and hepatobiliary systems.
    Knobler RM; Neumann RA; Gebhart W; Radaskiewicz T; Ferenci P; Widhalm K
    J Am Acad Dermatol; 1990 Aug; 23(2 Pt 2):341-6. PubMed ID: 2394852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Xanthoma disseminatum in a child with cranial bone involvement.
    Yağci B; Varan A; Altinok G; Söylemezoğlu F; Cila A; Büyükpamukçu M
    J Pediatr Hematol Oncol; 2008 Apr; 30(4):310-2. PubMed ID: 18391701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Rare case of xanthoma disseminatum with severe dyspnoea].
    Szyfter W; Wierzbicka M; Bem G
    Otolaryngol Pol; 2006; 60(1):67-70. PubMed ID: 16821545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Xanthoma disseminatum in an infant with skeletal and marrow involvement.
    Calverly DC; Wismer J; Rosenthal D; deSa D; Barr RD
    J Pediatr Hematol Oncol; 1995 Feb; 17(1):61-5. PubMed ID: 7743240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Xanthoma disseminatum: effective therapy with 2-chlorodeoxyadenosine in a case series.
    Khezri F; Gibson LE; Tefferi A
    Arch Dermatol; 2011 Apr; 147(4):459-64. PubMed ID: 21173305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bilateral laryngeal pseudoparalysis in xanthoma disseminatum treated by endoscopic laser medial arytenoidectomy.
    Cantarella G; Neglia CB; Marzano AV; Ottaviani A
    Ann Otol Rhinol Laryngol; 2001 Mar; 110(3):263-7. PubMed ID: 11269772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generalized eruptive histiocytoma developing into xanthoma disseminatum with central diabetes insipidus.
    Kobayashi K; Kurihara Y; Yamagami J; Ito J; Shima H; Shimada H; Ichimura C; Ishiko A; Amagai M; Ouchi T
    J Dermatol; 2019 Aug; 46(8):e281-e283. PubMed ID: 30859591
    [No Abstract]   [Full Text] [Related]  

  • 29. Xanthoma disseminatum with neurological involvement and optic atrophy: improvement with cladribine.
    Patra S; Bhatia S; Khaitan BK; Bhari N
    BMJ Case Rep; 2019 May; 12(5):. PubMed ID: 31118172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Xanthoma disseminatum with marked mucocutaneous involvement].
    Tietge UJ; Maschek H; Schneider A; Gawehn AE; Wagner S; Manns MP; Schmidt HH
    Dtsch Med Wochenschr; 1998 Nov; 123(45):1337-42. PubMed ID: 9835892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 12-1998. A 68-year-old man with a rash, diabetes insipidus, and laryngeal stenosis.
    N Engl J Med; 1998 Apr; 338(16):1138-43. PubMed ID: 9547140
    [No Abstract]   [Full Text] [Related]  

  • 32. Nodular lesions on the face and trunk. Xanthoma disseminatum (XD).
    Soong VY; Rabkin MS; Thomas JM
    Arch Dermatol; 1991 Nov; 127(11):1719, 1722. PubMed ID: 1952983
    [No Abstract]   [Full Text] [Related]  

  • 33. Photo quiz. Xanthoma disseminatum.
    Paolini TS; Helm TN
    Cutis; 2000 Jun; 65(6):351, 377-8, 384. PubMed ID: 10879300
    [No Abstract]   [Full Text] [Related]  

  • 34. The various clinical patterns of xanthoma disseminatum. Considerations on seven cases and review of the literature.
    Caputo R; Veraldi S; Grimalt R; Gianotti R; Tosti A; Varotti C; de Kaminsky AR
    Dermatology; 1995; 190(1):19-24. PubMed ID: 7894090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of xanthoma disseminatum with simvastatin.
    Lee EH; Kang TW; Kim SC
    J Dermatol; 2011 Oct; 38(10):1015-7. PubMed ID: 21592199
    [No Abstract]   [Full Text] [Related]  

  • 36. Disseminated intracranial xanthoma disseminatum: a rare case report and review of literature.
    Yang GZ; Li J; Wang LP
    Diagn Pathol; 2016 Aug; 11(1):78. PubMed ID: 27535029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral and Cutaneous Involvements of Xanthoma Disseminatum Successfully Treated with an Interleukin-1 Receptor Antagonist: A Case Report and Minireview.
    Campero M; Campero S; Guerrero J; Aouba A; Castro A
    Dermatology; 2016; 232(2):171-6. PubMed ID: 26741816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of xanthoma disseminatum: evaluation and monitoring by 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
    Jin S; Chae SY; Chang SE; Suh C; Lee SW; Ryu JS
    Br J Dermatol; 2014 May; 170(5):1177-81. PubMed ID: 24329687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of
    Chandekar KR; Satapathy S; Sharma A; Taneja N; Tripathi M; Bal C
    J Nucl Med Technol; 2023 Dec; 51(4):335-336. PubMed ID: 37699645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of cutaneous lesions of xanthoma disseminatum with a CO2 laser.
    Carpo BG; Grevelink SV; Brady S; Gellis S; Grevelink JM
    Dermatol Surg; 1999 Oct; 25(10):751-4. PubMed ID: 10594575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.